Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : LOM Medical International Inc.(LOMM)Nasdaq otc. -- Ignore unavailable to you. Want to Upgrade?

To: bcjt who wrote (19)	11/20/1999 2:29:00 PM
From: bcjt	Respond to of 97

L.O.M. Medical International Inc. Newsletter & Update Volume 3, Issue 4 Page 2 October/November 1999 Secretary of Labor in the U.S.A. Plans to Combat Needlestick Injuries The Occupational Safety and Health Administration is seeking to reduce the number of needlestick injuries to healthcare workers. Such injuries may spread illnesses and disease such as hepatitis and AIDS or HIV. They have estimated that 590,000 injuries occur from needlesticks each year. The Secretary of Labor, Alexis M. Herman, announced his opinions regarding this issue in a National News release on May 20, 1999. He said, "Safer needle devices mean fewer needlesticks for healthcare workers. It is time to make sure that healthcare workers have up-to-date medical devices that limit the risk of needlesticks and the potential for developing deadly diseases such as AIDS and hepatitis." OSHA is taking many steps to reduce the risks of healthcare workers contracting such diseases from needlestick injuries. The report has indicated that proper training, education, and the use of safer medical devices have proven to play an important role in reducing such risks. OSHA Administrator, Charles N. Jeffress stated "Health care workers strive to keep us healthy. We now have an opportunity to provide them with protection from the hazards of sharps and needlestick injuries that can threaten their heatlh and well-being. It's time to move forward." OSHA National News Release, U.S. Department of Labor, Office of Public Affairs, USDL: 99-145, Thursday May 20, 1999 HIV via Needlesticks: How can it be prevented? In many cases, the spread of HIV can be prevented. Prevention of HIV transmission to health care workers and care givers include the use of a safety syringe, safe work practices that do not allow the recapping of needles, (i.e. the L.O.M. Retractable Syringe) and the use of personal protective equipment like masks, protective eyewear, and vinyl gloves (a lot of allergies occur from latex). Also, in drug users, a safer retractable syringe like the L.O.M. Retractable, would not allow the sharing of needles as the syringe automatically retracts the needle and locks it into it's own sealed chamber. This would prevent a lot of drug users who are infected with HIV or Hepatitis from spreading this disease via their needlesticks. L.O.M. Directors' Meeting: On September 25th, 1999, the Directors of L.O.M. Medical International Inc., met in the Vancouver office boardroom for a scheduled board meeting. The topics discussed included: the annual audit and interm financial statements; reports to SEC. and NASDQ; reports on J. Alexander and Thomas Stepp pertaining to commencement of trading; quarterly and anually financial projections; report on negotiations with banks & brokerages; commencement of publically trading; share sales; production & marketing; new products; newsletters and correspondence. Odds n' Ends: The company is presently promoting its Eye Care Products in the United States. L.O.M. is in the final stages of taking on another product line for North America that has FDA approvals and DIN Numbers for the U.S. and Canada. This Product is presently being marketed in Europe as a medical, pharmaceutical, and "hospital use" product. The product line deals with skin disorder treatments, and has proven to be very effective in the treatment of Psoriasis, Eczema, and Acne. It has also proven to be very effective for use on burn unit patients. L.O.M. Medical International Inc. Headquarters Suite #3-1482 Springfield Road Kelowna, B.C., Canada V1Y 5V3 Tel.: (250) 762-7552 Fax: (250)762-6988 KELOWNA E-MAIL Vancouver Office Suite 580 - 885 Dunsmuir Street Vancouver, B.C., Canada V6C 3L6 Tel.: (604) 602-9400 Fax: (604) 602-9409 VANCOUVER E-MAIL bcjt

To: bcjt who wrote (19)	11/20/1999 2:30:00 PM
From: bcjt	Read Replies (1) \| Respond to of 97

L.O.M. Medical International Inc. Newsletter & Update Volume 3, Issue 4 Page 1 October/November 1999 From The President?s Desk Our Valued Shareholders: I would like to take this opportunity to update you on some of the events that have taken place since our last Newsletter. These events are very exciting and encouraging for a start-up Company such as L.O.M. Medical International. We are attracting high profile investors who are well known by the medical industry, as well as medical publishing journals that very often influence the brokerages and market makers who are out there promoting our stock to the various fund managers. This is becoming more evident as the company is getting closer to trading. At our September 25th , 1999 Board of Directors Meeting held in our Vancouver Office, I reported our position to the Board in regards to trading. The company is presently cleared to commence trading, and can do so, once the Board gives me the vote to go ahead and trade. The Board reminded me that certain objectives would have to be met before their approval to commence trading can be given, namely that the Offering Memorandum for the one million shares at $5.00 U.S. be placed. The Boards position on this matter was well supported at the Annual Shareholders Meeting, which was held in Kelowna on April 23, 1999. There are several companies we are negotiating with regarding the placement. L.O.M. Medical is currently negotiating with a New Jersey brokerage firm, who are major market makers for the Eastern United States. Sincerely, John Klippenstein, President & CEO L.O.M. Medical International Inc. is proud to announce the signing of a contract with Health Care Insights of Edison, New Jersey. Dr. Jeffrey Berg CEO of Health Care Insights attended a meeting at our Kelowna Office on October 12th, 1999 at which time the agreement was completed. Dr.Berg will be the prime consultant to L.O.M. Medical International Inc. on Product Analysis and valuations as well as strategic alliances with other Medical Corporations. Dr. Berg is a senior Research Analyst who has a Ph.D. in Chemistry and an MBA. He's a regular contributor to major American Medical Publications and is well respected in the Medical and Health care industry. He specializes in Pharmaceutical, Biotechnology, Medical Devises, and Diagnostic Products, he primarily focuses on emerging growth Companies. Dr. Berg has a broad and extensive background as prime consultant to major Medical Companies and is well known in the Industry worldwide. H.M. Meyerson & Co. of New Jersey use Dr. Jeffrey Berg as their senior analyst for new and emerging Medical Technology and Biotechnology Companies. It was at the recommendation of H.M Meyerson that L.O.M. Medical International Inc. got its introduction to Dr. Berg. L.O.M. Medical International Inc. Stock will be offered through H.M. Meyerson of New Jersey as Market Maker for the Eastern part of the United States. Alexander & Company will be L.O.M.`s Market Maker for the Pacific Western part of the United States. We'd like To Know: At L.O.M. we are always concerned about hearing from you! Our Shareholders are an important part of our Company, and we are interested in receiving your input and comments. Please e-mail your comments or suggestions to our offices. Hope to hear from you soon! ...Directors & Staff bcjt